[1] BLAESE R M, CULVER K W, MILLER A D, et al. T lymphocyte-directed gene therapy for ADA-SCID initial trial results after 4 years[J]. Science,1995,270(5235):475-480.
[2] WIRTH T, PARKER N, YLÄ-HERTTUALA S. History of gene therapy[J]. Gene,2013,525(2):162-169.
[3] RAPER S E, CHIRMULE N, LEE F S, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer[J]. Mol Genet Metab,2003,80(1/2):148-158.
[4] MURALI R,APARNA N. Non viral vectors in gene therapy-an overview[J]. Clin Diagn Res,2015,9(1):1-6.
[5] KOGURE K, MORIGUCHI R, SASAKI K, et al. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method[J]. Control Release, 2004, 98(2):317-323.
[6] SOKOLOVA V, EPPLE M. Inorganic nanoparticles as carriers of nucleic acids into cells[J]. Angew Chem Int Ed Engl,2008,47(8):1382-1395.
[7] KEMP J A, SHIM M S, HEO C Y, et al. "Combo" nanomedicine:Co-delivery of multi-modal therapeutics for efficient, targeted,and safe cancer therapy[J]. Adv Drug Deliv Rev,2016, 98(10):3-18.
[8] SARA P, GREGOR S. Magnetic nanoparticles as targeted delivery systems in oncology[J]. Radiol Oncol,2011,45(1):1-16.
[9] ALEXIOU C, JURGONS R. Magnetic drug targeting[M]//ANDRÄ W, NOWAK H. Magnetism in medicine:a handbook. Berlin:Wiley-VCH,2007:596-605.
[10] WU C, GONG F, PANG P, et al. An RGD-modified MRIvisible polymeric vector for targeted sirna delivery to hepatocellular carcinoma in nude mice[J]. PLoS One,2013,8(6):e66416.
[11] GUO Y,WANG J,ZHANG L,et al. Theranostical nanosystemmediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma[J]. Hepatology, 2016, 63(4):1240-1255.
[12] YANG H W, HUANG C Y, LIN C W, et al. Gadoliniumfunctionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging[J]. Biomaterial,2014,35(24):6534-6542.
[13] LIN G,ZHU W,YANG L,et al. Delivery of siRNA by MRIvisible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells[J]. Biomaterials,2014,35(35):9495-9507.
[14] YANG H, LI Y, LI T T, et al. Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer[J]. Sci Rep,2014,4(4):7072.
[15] WANG C,DING C,KONG M,et al. Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo[J]. Biochem Biophys Res Commun,2011,410(3):537-542.
[16] LI H, FU C, MIAO X, et al. Multifunctional magnetic codelivery system coated with polymer mPEG-PLL-FA for nasopharyngeal cancer targeted therapy and MR imaging[J]. J Biomater Appl,2017,31(8):1169-1181.
[17] ALKILANY A M,THOMPSON L B,BOULOS S P,et al. gold nanorods:their potential for photothermal therapeutics and drug delivery,tempered by the complexity of their biological interactions[J]. Adv Drug Deliv Rev,2012,64(2):190-199.
[18] SHEN J L, KIM H C, MU C F, et al. Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy[J]. Adv Healthc Mater,2014,3(10):1629-1637.
[19] YANG Z Z, LIU T F, XIE Y, et al. Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer[J]. Acta Biomaterialia,2015,25(7):194-204.
[20] WANG D, WANG T, XU Z, et al. Cooperative treatment of metastatic breast cancer using host-guest nanoplatform coloaded with docetaxel and siRNA[J]. Small,2016,12(4):488-498.
[21] YIN F, HU K, CHEN Y Z, et al. SiRNA delivery with PEGylated graphene oxide nanosheets for combined photothermal and gene therapy for pancreatic cancer[J]. Theranostics,2017,7(5):1133-1148.
[22] WANG L, SHI J, ZHANG H, et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes[J]. Biomaterials, 2013,34(1):262-274.
[23] VIJAYANATHAN V, THOMAS T, THOMAS T J. DNA nanoparticles and development of DNA delivery vehicles for gene therapy[J]. Biochemistry,2002,41(48):14085-14094.
[24] ZHENG C, ZHENG M, GONG P, et al. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy[J]. Biomaterials, 2013, 34(13):3431-3438.
[25] ZHENG Y, CHEN H, ZENG X, et al. Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy[J]. Nanoscale Res Lett,2013,8(1):161.
[26] XIONG Q, CUI M, BAI Y, et al. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-llysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma[J]. Colloids Surf B Biointerfaces,2017,155(4):93-103.
[27] REDDY T L, GARIKAPATI K R, REDDY S G, et al. Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pHSensitive liposomal nanocarrier for the synergistic treatment of melanoma[J]. Sci Rep,2016,6:35223.
[28] ZHANG F, LI M, SU Y, et al. A dual-targeting drug codelivery system for tumor chemo-and gene combined therapy[J]. Mater Sci Eng C Mater Biol Appl,2016,64(3):208-218.
[29] LEE S Y, YANG C Y, PENG C L, et al. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy[J]. Biomaterials,2016,86(1):92-105.
[30] YU D, LI W, ZHANG Y, et al. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment[J]. Biomed Pharmacother,2016,83(1):1428-1435.
[31] TAO W, JAYDEV R U, VLADIMIR P T. Design of multifunctional non-viral gene vectors to overcome physiological barriers:Dilemmas and strategies[J]. Pharmaceutics, 2012, 421(1):3-20. |
